Insider filing · TVTX
Gary A Lyons
Director
profile →
Travere Therapeutics, Inc.
TVTX · Healthcare · 73 filings in 24 months
ticker →
Gary A Lyons sold $329K of Travere Therapeutics (TVTX)
Executed Apr 14, disclosed Apr 16, 2 days later.
Value, as filed
$329K
8,000 sh × $41.07
Executed
Apr 14
the trade date, as filed
Disclosed
Apr 16
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GLGary A Lyons (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $2.3M of NBIX (15,000 sh × $152.61, as filed), executed Dec 3 2025.
The name
TVTXHealthcare · Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Gary A Lyons in TVTX
TVTXSALE
Travere Therapeutics, Inc.
$543K8,600 sh across 3 lots
Exec Aug 17
Filed Aug 19 · 4:05 PM ET